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ASPM is a protein required for the correct assembly and function of microtubule spindles. It 
participates in human brain development as well and is overexpressed in all tumours studied 
so far. We are interested in further characterizing ASPM function as it is unclear why it 
affects brain growth and is related to cancer. This prompted us to isolate ASPM-binding 
proteins. We found that EGFR (Epidermal Growth Factor Receptor), a protein highly involved 
in cancer, would bind ASPM. Furthermore, ASPM promotes activation of EGFR by 
phosphorylation resulting in a more active MAP kinase pathway. Our findings explain the 
involvement of ASPM in cancer, set ASPM as a new therapeutic target, and demonstrate a 
novel activity of the protein not related to mitosis. 
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